CSTL Sale Disclosure
Juvenal Tobin W · SEC Form 4 · Filed Sep 16, 2026
Sale
Calculated transaction value
$115.76K
Juvenal Tobin W Chief Commercial Officer
CSTL
Castle Biosciences
CSTL
Transaction date
Sep 15, 2026
Public filing date
Sep 16, 2026
Filing lag
Filed 1 day later
CSTL daily price context
Close on/before transaction
$35.5
Sep 15, 2026
Close before public filing
$35.5
Sep 15, 2026
Return since public filing
-2.27%
Through Sep 21, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,294 shares @ $35.14
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001628280-26-062255
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$222.62K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Castle Biosciences Inc CSTL Current | Sale | Sep 15, 2026 | $115.76K |
| Castle Biosciences Inc CSTL | Sale | Sep 14, 2026 | $106.86K |